港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

恒瑞医药

67.200

+1.5502.36%

成交量：3.56万

成交额：239.23万

市值：4,460.06亿

市盈率：49.49

高：67.200

开：67.200

低：67.200

收：65.650

52周最高：95.200

52周最低：52.500

股本：66.37亿

香港流通股本：2.58亿

量比：- -

换手率：0.01%

股息：- -

股息率：- -

每股收益(LYR):1.358

净资产收益率：14.31%

总资产收益率：8.42%

市净率：6.33

市盈率(LYR):49.49

市销率: 12.26

数据加载中...

总览公司新闻资讯公告

恒瑞医药新药来袭：国产首个ANGPTL3靶点冲刺上市，降脂市场格局将变！

摩熵医药大数据

中邮证券：siRNA药物机制优势突出递送为核心技术

智通财经网

英伟达、港股科技、创新药怎么了？财报季慌了，熬过三板斧！

近期人民币独立行情：三大核心逻辑

华尔街见闻

恒瑞1类新药大爆发，1000亿市场波澜再起

每日卖空追踪 | 恒瑞医药 02月26日卖空量成交8.76万股，卖空比例为4.85%

江苏恒瑞医药（600276）回购27.6万股A股，总额约1563万元人民币

恒瑞医药(01276)2月26日斥资1563.03万元回购27.6万股A股

恒瑞医药盘中异动临近收盘快速下挫3.01%报65.950港元

抗失眠症药物领域再迎喜讯，该药企1类创新药获批临床

【市场】17个国谈药拟进院，独家品种霸屏

国泰海通：FXI引领抗凝药产业新变革多技术路线竞逐蓝海

恒瑞医药：1类创新药SHR-1918注射液获受理并纳入优先审评程序

阿斯达克财经

标普全球市场财智列出近期十大沽空比例最高港股

阿斯达克财经

重新审视BigPharma创新质地：恒瑞、石药、中生、翰森、先声……

恒瑞医药(01276)出现大手成交10万股，成交价$69.7，涉资697万

阿斯达克财经

2.2类改良，恒瑞医药2款1类新药迎来新进展

北京药研汇

《大行》野村料恒瑞医药今年净利润增长三成降目标价至87.49元续吁“买入”

阿斯达克财经

这款肿瘤药断供数月，患者陷入困境实探“封门”风波中的璎黎药业，现场工作人员：整体搬迁，经营没有大问题

江苏：医保搭台推进创新药落地再提速

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/01276/news?page=7"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恒瑞医药","latestPrice":67.2,"timestamp":1776216005292,"preClose":65.65,"halted":0,"volume":35600,"delay":0,"changeRate":0.023610053313023564,"floatShares":258000000,"shares":6637000000,"eps":1.357670796016392,"marketStatus":"开市前","change":1.55,"latestTime":"04-15 09:25:49","open":67.2,"high":67.2,"low":67.2,"amount":2392320,"amplitude":0,"askPrice":67.3,"askSize":3200,"bidPrice":67.2,"bidSize":2800,"shortable":3,"etf":0,"ttmEps":1.357670796016392,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776216600000},"marketStatusCode":1,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":65.65,"openAndCloseTimeList":[[1776216600000,1776225600000],[1776229200000,1776240000000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恒瑞医药","latestPrice":57.94,"timestamp":1776216323000,"preClose":56.18,"halted":0,"volume":1764200,"delay":0,"premium":"+0.80"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"8.42%","roe":"14.31%","lyrEps":1.357745,"shares":6637000000,"dividePrice":0,"high":67.2,"amplitude":0,"preClose":65.65,"low":67.2,"week52Low":52.5,"pbRate":"6.33","psRate":"12.26","week52High":95.2,"institutionHeld":0,"latestPrice":67.2,"committee":-0.066667,"eps":1.3577446471800254,"divideRate":0,"volume":35600,"delay":0,"ttmEps":1.3577446471800254,"open":67.2,"prevYearClose":71.25,"fiveDayClose":66.65,"twentyDayClose":64,"sixtyDayClose":78.7,"earningDate":1776873600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-04-23","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776907800000,"name":null,"time":"","dateTimestamp":1776873600000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null},{"date":"2025-08-21","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755739800000,"name":null,"time":"","dateTimestamp":1755705600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.6667,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1772208000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-04-13","current":48.380622,"percent":0.013699,"low":44.415436,"twenty":50.932338,"median":54.869473,"eighty":60.172857,"high":65.582363,"avg":55.316763,"sd":4.843086,"marketCap":419466533632.58},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-13","current":47.438857,"twenty":50.932338,"median":54.869473,"eighty":60.172857,"marketCap":419466533632.58}],"updateTime":1776197486060},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614286009","title":"恒瑞医药新药来袭：国产首个ANGPTL3靶点冲刺上市，降脂市场格局将变！","url":"https://stock-news.laohu8.com/highlight/detail?id=2614286009","media":"摩熵医药大数据","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614286009?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 15:59","pubTimestamp":1772179198,"startTime":"0","endTime":"0","summary":"截图来源：企业公告这不仅意味着中国首个ANGPTL3靶点药物即将破局，更标志着恒瑞在“First-in-class”创新药研发的征途上，又迈出了坚实的一步。ANGPTL3近年稳居降脂领域的“明星靶点”。其中，ANGPTL3单抗因覆盖HoFH及混合型高脂血症等广泛人群，被视为这一“百亿级”细分赛道的重要组成。参考全球市场趋势，ANGPTL3靶点药物在中国有望成长为百亿级规模的降脂赛道，而恒瑞的率先突破，将在这一进程中掌握主动权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227160629a4ceeeba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227160629a4ceeeba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","LU0359201612.USD","LU0359202008.SGD","LU2543165471.USD","LU1023057109.AUD","LU0359201885.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2614699958","title":"中邮证券：siRNA药物机制优势突出 递送为核心技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2614699958","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614699958?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 11:04","pubTimestamp":1772161440,"startTime":"0","endTime":"0","summary":"中邮证券发布研报称，siRNA药物可精准沉默致病蛋白，优势显著，递送系统为核心技术。海外巨头基于GalNAc肝递送平台，针对心血管靶点的药物已进入收获期。中邮证券主要观点如下：siRNA药物机制优势突出，递送为核心技术相较于传统小分子和生物药，siRNA药物为代表的核酸疗法可精准沉默致病蛋白，高效降解且作用时间长，目前已成为新药开发热门方向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227120913a72505ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227120913a72505ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06938","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614400309","title":"英伟达、港股科技、创新药怎么了？财报季慌了，熬过三板斧！","url":"https://stock-news.laohu8.com/highlight/detail?id=2614400309","media":"木鱼ETF","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614400309?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 08:24","pubTimestamp":1772151886,"startTime":"0","endTime":"0","summary":"并且，这是连续2个交易日出现明显离场迹象。一个可能的解释，还是担忧财报冲击，尤其是3月还有腾讯阿里的财报，美团一个季度亏200多亿，机构慌了。因此，我们可能不得不做出一个心理预期：今年的机构，可能会对财报特别挑剔甚至提前悲观预判，大家也可能需要熬过3月机构可能的“三板斧”。#英伟达 #百济神州 #百度 #恒生科技 #港股科技 #ETF #基金","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022708341897a73647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022708341897a73647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","01347","00981","09992","00883","80883","03690","09988","06978","02628","06869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614028794","title":"近期人民币独立行情：三大核心逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2614028794","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614028794?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 22:21","pubTimestamp":1772115700,"startTime":"0","endTime":"0","summary":"本轮人民币升值的三个核心驱动逻辑：结汇需求释放、PPI上行、资本市场回报率改善。而近期这三个因素正在形成积极共振，共同推动本轮人民币的主动升值。而近期PPI上行趋势的进一步确认，正在为人民币主动升值提供助力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226222352a722d6de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226222352a722d6de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0594300179.USD","LU0348783662.USD","LU0315178854.USD","LU1048484197.HKD","LU0605514214.HKD","LU0051755006.USD","LU1880398471.USD","LU0039217434.USD","LU0314109678.HKD","LU0043850808.USD","LU1303224171.USD","LU0197773160.USD","LU0823038988.USD","ALBmain","LU0359201885.HKD","LU0235996351.USD","LU0396098781.USD","LU0164865239.USD","HK0000306685.HKD","LU1115378108.SGD","LU1981816686.USD","LU0128522157.USD","LU0640798160.USD","LU0856984785.SGD","SG9999000459.SGD","LU0868486357.SGD","IE00B5MMRT66.SGD","LU0762542818.HKD","LU0577902371.SGD","LU0315179316.USD","LU0577902538.SGD","LU0588546209.SGD","LU0675040207.SGD","LU1366334651.USD","LU0651947912.USD","LU0608807946.USD","LU0417516571.SGD","89988","LU1211504680.USD","LU0384037296.USD","LU0672654166.SGD","LU1655091459.SGD","LU0823413587.USD","LU1642822792.SGD","LU0890818403.SGD","LU0516422440.USD","LU1282649141.HKD","LU0029874905.USD","LU0871576103.HKD","LU0708995583.HKD","LU0431992006.USD","LU0831093199.SGD","LU0561508036.HKD","LU1044876610.USD","LU0608807433.USD","LU0456827905.SGD","LU0898667661.SGD","LU0047713382.USD","LU0320764243.SGD","01276","LU0823039010.USD","LU0762541174.USD","LU0862451837.USD","LU0417516902.SGD","LU2087589342.USD","LU0577902454.USD","LU0516423091.SGD","IE00BPRC5H50.USD","HK0000320223.HKD","LU0531970944.HKD","LU0828237510.HKD","09988","LU0348805143.USD","SGXZ90724238.SGD","LU0831103253.SGD","LU1328615791.USD","LU0499858438.USD","LU0540923850.HKD","LU0594300419.USD","LU0572940350.SGD","LU0708995153.HKD","LU2476274720.SGD","IE00BZ08YR35.GBP","BK1521","LU1961090484.USD","LU0516422366.SGD","LU2097828474.EUR","LU2257852520.SGD","LU0588545490.SGD","BK1588","LU0588545904.SGD","LU0127658192.USD","LU2097828805.USD","LU0737861699.HKD","LU0143863198.USD","BK1591","LU0502904849.HKD","LU1770036033.HKD","LU2357305700.SGD","LU0164872284.USD","LU0327786744.USD","LU1023057109.AUD","LU1282651121.HKD","LU3063872942.SGD","LU1282651048.USD","LU0106959298.USD","LU0132412106.USD","LU0359202008.SGD","BK1142","LU1880398554.USD","LU0048580855.USD","LU0650527681.SGD","LU0370786039.SGD","LU0106259558.USD","LU1719994722.HKD","LU1224444064.USD","IE0034224299.USD","LU0541501648.USD","LU1807302812.USD","LU1769817096.USD","SGXZ86797644.SGD","LU0588545730.USD","LU0117844026.USD","LU1808992512.USD","LU0823397285.USD","LU1048588211.SGD","LU1439103000.SGD","LU0648000940.SGD","LU2097828631.EUR","01880","BK1615","LU1504937902.USD","LU0329678337.USD","LU0329678170.USD","LU1282649067.USD","LU2045819591.USD","LU0048597586.USD","LU0345775950.USD","LU1868838027.USD","BK1575","LU0228367735.SGD","LU0210526637.USD","LU0823041008.USD","LU2242644610.SGD","LU0149534421.HKD","LU0130518102.USD","LU0348827113.USD","LU0630378429.USD","LU0823413660.USD","LU2293587155.HKD","LU1196710864.SGD","LU2778985437.USD","HK0000320264.USD","LU1515016050.SGD","LU0359201612.USD","LU1880383440.USD","SG9999001903.USD","LU1956131251.USD","SG9999006514.SGD","BK1584","LU0054237671.USD","LU0163747925.USD","LU0061477393.USD","LU0264606111.USD","LU0762540952.USD","LU1366334578.USD","LU0455707207.USD","LU1051769294.HKD","LU0320764755.SGD","HK0000306701.USD","LU1242518857.USD","LU0572939691.SGD","LU1813983027.USD","01179","IE00B0JY6N72.USD","LU0819121731.USD","BK1586","LU1242518931.SGD","LU0169518387.USD","LU0181495838.USD","LU0054450605.USD","LU0449509016.USD","LU0630378692.HKD","LU0737861772.HKD","LU0577902611.USD","LU1048596156.SGD","LU0979878070.USD","LU0084288322.USD","LU0196878994.USD","LU0823426308.USD","LU0700851271.USD","LU0823397103.USD","LU1282649810.SGD","LU0128522744.USD","LU0456846285.SGD","LU0543330483.HKD","LU1328277881.USD","LU1770034418.SGD","LU1568876251.USD","LU0348825331.USD","LU0531971595.HKD","HBBD.SI","LU0516423174.USD","IE0008368304.USD","LU0251144936.SGD","LU0589944569.HKD","IE00BMPRXN33.USD","BK1502","LU1880383366.USD","LU0463099449.HKD","LU0293314216.USD","00753","IE00BZ08YT58.USD","LU0143863784.USD","LU0823040885.USD","LU0488056044.USD","LU1688375341.USD","LU1044875133.USD","LU1044874839.SGD","BK1249","LU0261947096.USD","LU2097829019.USD","LU0140636845.USD","LU0072462343.USD","SG9999006597.SGD","IE00BZ08YS42.EUR","LU0348784397.USD","LU1251922891.USD","LU0821914370.USD","LU0823426480.USD","SG9999004220.SGD","SG9999014674.SGD","00763","LU0791591158.USD","LU0307460666.USD","LU0862451753.SGD","LU0261950983.USD","LU1568876335.HKD","LU0348735423.USD","LU1323998911.USD","LU1316542783.SGD","LU1188198961.HKD","LU0541502299.USD","LU1794554557.SGD","LU0651946864.USD","LU2399975544.HKD","LU2039709279.SGD","SG9999001093.SGD","LU0348783233.USD","LU0449515922.USD","LU2488822045.USD","LU1481107354.HKD","LU0417516738.SGD","SG9999001689.USD","LU1993786604.SGD","LU1201861165.SGD","LU0348788117.USD","LU0049853897.USD","LU0828237940.HKD","IE00B3M56506.USD","LU0165289439.USD","LU2097828714.EUR","03750","LU0210527791.USD","LU0197773673.USD","LU0516422952.EUR","LU0259732245.USD","LU0634319403.HKD","LU1720050803.USD","LU0607220059.USD","LU1810669033.SGD","LU0326950275.SGD","LU0149721374.USD","LU0572944931.SGD","LU0173614495.USD","LU0287142896.SGD","BK1501","SG9999002828.SGD","IE00B543WZ88.USD","LU0577902298.EUR","LU0328353924.USD","LU2125910500.SGD","LU1051768304.USD","LU1769817179.HKD","LU0048388663.USD","IE00BMPRXR70.SGD","LU2476274308.USD","IE0032431581.USD","LU0011963245.USD","LU0611395673.USD","LU0214875030.USD","SG9999000327.SGD","SG9999002562.SGD","LU1720051017.SGD","LU0096374516.USD","LU0130103400.USD","LU1831875114.USD","LU1960683339.HKD","SGXZ62798434.SGD","LU0441854154.USD","LU0477156797.USD","LU0791590937.USD","LU0593848301.USD","LU0320764599.SGD","LU2097828557.USD","BK1610","LU0164880469.USD","LU0052750758.USD","601377","LU0648948544.HKD","LU1868837565.USD","LU0642271901.SGD","IE0003895053.USD","LU0106252389.USD","LU0229945570.USD","LU0819123356.HKD","BK1608","LU0784639295.USD","SG9999001226.SGD","LU0865486749.SGD","LU0499858602.USD","BK1618","LU0231483743.USD","LU0543330566.HKD","LU0886674414.USD","LU1720051108.HKD","LU0211977185.USD","LU0117841782.USD","LU2125910849.SGD","LU0873338254.USD","LU1548497426.USD","BK1517","LU2449936058.SGD","IE00B0169N27.USD","LU0029875118.USD","LU0254981946.USD","LU0345776255.USD","SG9999001051.SGD","SG9999002463.SGD","LU0469268626.HKD","LU0244354667.USD","LU2152927971.USD","LU0228659784.USD","LU1224709979.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2614029077","title":"恒瑞1类新药大爆发，1000亿市场波澜再起","url":"https://stock-news.laohu8.com/highlight/detail?id=2614029077","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614029077?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 16:47","pubTimestamp":1772095620,"startTime":"0","endTime":"0","summary":"精彩内容日前，恒瑞医药发布公告，其子公司北京盛迪医药的1类创新药SHR-1918注射液上市申请获CDE受理，且已被纳入优先审评程序，用于治疗成人和12岁及以上的未成年人纯合子家族性高胆固醇血症患者。米内网数据显示，心脑血管系统药物（化+生）在近年中国三大终端六大市场均超过1000亿元销售规模，2025年Q1-Q3同比有所下滑。从亚类来看，血脂调节剂（化+生）逆势大涨超过15%。截至目前，SHR-1918注射液相关项目累计研发投入约2.42亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226200322a722611a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226200322a722611a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","LU2543165471.USD","LU0359201885.HKD","LU0359201612.USD","LU1023057109.AUD","01276","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614029002","title":"每日卖空追踪 | 恒瑞医药 02月26日卖空量成交8.76万股，卖空比例为4.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614029002","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614029002?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 16:30","pubTimestamp":1772094620,"startTime":"0","endTime":"0","summary":"恒瑞医药北京时间02月26日，跌2.94%，卖空量成交8.76万股，较上一交易日减少76.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163233a4cab3ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163233a4cab3ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","LU0359202008.SGD","LU0359201885.HKD","LU2543165471.USD","BK1191","LU1023057109.AUD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110013295","title":"江苏恒瑞医药（600276）回购27.6万股A股，总额约1563万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=1110013295","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110013295?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 16:21","pubTimestamp":1772094096,"startTime":"0","endTime":"0","summary":"2026年2月26日，江苏恒瑞医药股份有限公司（股票代码：600276）公告回购A股股份，用于A股员工持股计划。公司于当日通过上海证券交易所买入276,000股，占回购前已发行股本约0.0043%。本次回购价格区间为每股人民币56.61元至56.69元，合计支付约人民币15,630,280元。\n本次回购完成后，公司已发行股份总数维持在6,379,002,274股，已发行股份（不含库藏股）变动为6,373,467,624股，库藏股份增至5,534,650股。公司确认已遵守相关上市规则和法律法规。\n本次公告由联席公司秘书刘笑含代表公司签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614018284","title":"恒瑞医药(01276)2月26日斥资1563.03万元回购27.6万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614018284","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614018284?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 16:20","pubTimestamp":1772094053,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(01276)发布公告，于2026年2月26日斥资1563.03万元回购27.6万股A股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0183","LU1146622755.USD","LU1997245177.USD","LU0359202008.SGD","LU1064130708.USD","LU2289578879.USD","LU2495084118.USD","399300","LU0405327148.USD","LU1328615791.USD","BK0012","BK0196","BK0239","01276","LU2148510915.USD","LU1580142542.USD","LU1781817850.SGD","BK0060","LU2097828474.EUR","LU1969619763.USD","LU1997245094.SGD","LU2097828557.USD","LU1820825898.SGD","BK0028","LU1255011170.USD","LU2097828631.EUR","LU0359201612.USD","LU0359201885.HKD","BK0188","LU2580892862.HKD","LU1997244956.HKD","LU2328871848.SGD","LU2580892789.USD","LU2488822045.USD","BK1191","LU2097828805.USD","159982","LU1023057109.AUD","LU2543165471.USD","600276","LU2097828714.EUR","LU1655091616.SGD","LU1064131003.USD","LU0405327494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614290060","title":"恒瑞医药盘中异动 临近收盘快速下挫3.01%报65.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614290060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614290060?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 15:59","pubTimestamp":1772092771,"startTime":"0","endTime":"0","summary":"2026年02月26日临近收盘15时59分，恒瑞医药股票出现异动，股价急速下挫3.01%。截至发稿，该股报65.950港元/股，成交量174.897万股，换手率0.68%，振幅3.09%。资金方面，该股资金流入4087.72万港元，流出6414.63万港元。最近的财报数据显示，该股实现营业收入253.98亿港元，净利润62.99亿港元，每股收益0.97港元，毛利218.98亿港元，市盈率64.02倍。恒瑞医药股票所在的药品行业中，整体跌幅为1.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226155931954212a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226155931954212a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","LU0359201612.USD","LU0359202008.SGD","LU2543165471.USD","LU1023057109.AUD","LU0359201885.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614802900","title":"抗失眠症药物领域再迎喜讯，该药企1类创新药获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2614802900","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614802900?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 14:14","pubTimestamp":1772086496,"startTime":"0","endTime":"0","summary":"据悉，近日康弘药业传来喜讯，公司自主研发的化药1类创新药KHN707片已获得国家药品监督管理局下发的药物临床试验批准通知书，同意该药品开展用于失眠症的临床试验。据悉，在抗失眠症新药领域，目前扬子江药业、恒瑞医药、豪森药业、信立泰等多家药企均有布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226141954a7211872&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226141954a7211872&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","LU0359201885.HKD","BK1161","LU0359201612.USD","06978","BK1191","LU0359202008.SGD","LU1023057109.AUD","BK1574","LU2543165471.USD","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614554709","title":"【市场】17个国谈药拟进院，独家品种霸屏","url":"https://stock-news.laohu8.com/highlight/detail?id=2614554709","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614554709?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 16:07","pubTimestamp":1772006826,"startTime":"0","endTime":"0","summary":"精彩内容近日，成都市第六人民医院发布招标公示，将组织拟引入药品生产企业遴选工作。17个新药在列，均为国谈药，涵盖化学药及生物药，既有环泊酚注射液等超10亿大品种，亦有芦比前列酮软胶囊、替戈拉生片等2025年前三季度销售额增速达三位数的高增长品种。17个新药均为国谈药，目前均已纳入国家医保乙类目录，主要集中在消化系统及代谢、神经系统、心脑血管系统等治疗领域，可见以慢病药、常见病药为主。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602251615059541ed56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602251615059541ed56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002793","NVOH","002653","LU1093756168.USD","NVOX","01276","BK4588","IE00BKVL7J92.USD","NVO","BK4599","NVS","BK4585","BK4007","IE00BZ1G4Q59.USD","LU1093756325.SGD","600276","BK4532","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2614772030","title":"国泰海通：FXI引领抗凝药产业新变革 多技术路线竞逐蓝海","url":"https://stock-news.laohu8.com/highlight/detail?id=2614772030","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614772030?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 13:37","pubTimestamp":1771997868,"startTime":"0","endTime":"0","summary":"FXI开启抗凝新时代，多技术路线竞逐蓝海研究表明，凝血因子XI是推动病理性血栓的重要因子，但在大多数情况下对正常止血并非必需，比如具有遗传性FXI缺乏的人群，血栓事件的发生率明显降低，而自发性出血的风险并未显著增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0183","BK1147","BK1191","LU2543165471.USD","BK0276","BK1564","BK1161","BK0012","LU0359201612.USD","LU0359202008.SGD","BK0184","02611","LU1023057109.AUD","BK0028","06938","LU0359201885.HKD","601211","BK0201","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613796385","title":"恒瑞医药：1类创新药SHR-1918注射液获受理并纳入优先审评程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2613796385","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613796385?lang=zh_cn&edition=fundamental","pubTime":"2026-02-24 16:41","pubTimestamp":1771922460,"startTime":"0","endTime":"0","summary":"2月24日丨恒瑞医药(600276.SH) 公告称，公司子公司北京盛迪医药有限公司收到国家药监局下发的《受理通知书》，公司1类创新药SHR-1918注射液的药品上市许可申请获受理，且已被纳入优先审评程序。该药品用于治疗成人和12岁及以上的未成年人纯合子家族性高胆固醇血症（HoFH）患者。SHR-1918注射液是公司自主研发的血管生成素样蛋白3（ANGPTL3）单克隆抗体，通过抑制ANGPTL3的活性，从而降低血清中的甘油三酯（TG）和LDL-C水平。截至目前，相关项目累计研发投入约2.42亿元。(A股报价延迟最少十五分钟。)新闻来源 (不包括新闻图片): 格隆汇","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250603120315070_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250603120315070_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/GLH2313304L/latest-news/GLH","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/GLH2313304L/latest-news/GLH","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0188","LU1580142542.USD","LU2097828714.EUR","BK1574","LU1997245094.SGD","BK0012","LU2580892789.USD","LU0405327494.USD","BK1161","BK1191","BK0196","LU1781817850.SGD","LU1997244956.HKD","LU1655091616.SGD","LU2148510915.USD","LU1997245177.USD","LU2289578879.USD","LU1146622755.USD","LU2097828805.USD","BK0060","LU0359201612.USD","LU1820825898.SGD","LU2097828631.EUR","LU2328871848.SGD","LU2543165471.USD","600276","LU1064130708.USD","LU2097828474.EUR","LU0405327148.USD","LU2097828557.USD","159992","LU2488822045.USD","LU1255011170.USD","LU1064131003.USD","LU1328615791.USD","01276","BK0239","LU1023057109.AUD","LU1969619763.USD","LU2495084118.USD","06978","LU2580892862.HKD","BK0028","LU0359202008.SGD","LU0359201885.HKD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613757157","title":"标普全球市场财智列出近期十大沽空比例最高港股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613757157","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613757157?lang=zh_cn&edition=fundamental","pubTime":"2026-02-24 10:03","pubTimestamp":1771898580,"startTime":"0","endTime":"0","summary":"标普全球市场财智列出截至上周五在香港十大沽空比例最高港股。数据是根据来自标普全球市场财智的证券金融数据集计算得出。计算沽空的指标为借出股份占已发行股份总数的百分比。沽空资料截至 2026-02-23 16:25。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190627142633458_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190627142633458_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1504339/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1504339/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2399975544.HKD","LU0651947912.USD","BK1147","LU0417516738.SGD","LU0675040207.SGD","LU1224444064.USD","LU1303224171.USD","600276","LU0067412154.USD","LU0823426480.USD","82318","LU1044876610.USD","LU1146622755.USD","LU2476274308.USD","LU2424517915.HKD","IE00BZ08YR35.GBP","BK1110","LU0738912210.USD","SG9999000459.SGD","BK1184","LU1769817179.HKD","LU1282651048.USD","LU1282649810.SGD","LU2476274720.SGD","BK1550","00177","LU1023057109.AUD","LU1226287529.USD","LU0164865239.USD","LU0865486749.SGD","LU2293587155.HKD","LU0326950275.SGD","LU0384037296.USD","601318","LU0607220059.USD","002768","LU0831103253.SGD","BK1116","LU0594300419.USD","LU0164872284.USD","LU0049112450.USD","SG9999001440.SGD","BK1507","LU0315179316.USD","LU0762541174.USD","LU1115378108.SGD","BK1149","600377","BK1529","HK0000306701.USD","SG9999002828.SGD","LU0414403682.SGD","LU0370786039.SGD","LU0588545904.SGD","LU0072913022.USD","LU0856984785.SGD","LU0898667661.SGD","LU0048580855.USD","SG9999014674.SGD","LU1880383440.USD","LU1328277881.USD","LU0315178854.USD","LU1251922891.USD","LU1282649141.HKD","BK1610","03145","SG9999001903.USD","LU2153591404.USD","LU0882747503.HKD","LU1770034418.SGD","LU0011963245.USD","BK1526","LU0140636845.USD","LU0348825331.USD","00763","BK1567","HK0000320264.USD","BK1535","02202","BK1505","IE00BMQBXF63.USD","LU0572944931.SGD","LU0831093199.SGD","LU1993786604.SGD","LU1051769294.HKD","LU0235996351.USD","LU0197773160.USD","LU1807302812.USD","HPAD.SI","LU0348814723.USD","HK0000306685.HKD","LU1794554557.SGD","LU0359202008.SGD","IE00BZ08YS42.EUR","LU1720050803.USD","BK1546","LU1282649067.USD","LU0181495838.USD","LU0828237510.HKD","LU1105468828.SGD","LU1366334651.USD","LU0228659784.USD","01072","LU0348788117.USD","LU0871576103.HKD","LU0878004406.USD","LU0630378692.HKD","IE0008369823.USD","LU0320764599.SGD","LU0210527791.USD","LU0039217434.USD","LU0149534421.HKD","LU0449515922.USD","LU1046422090.SGD","PAImain","IE00BGHQDM52.EUR","LU0051755006.USD","LU0314109678.HKD","LU0228367735.SGD","BK1240","LU0605514214.HKD","LU1282648689.USD","LU1981816686.USD","LU0348783233.USD","LU0588545730.USD","LU0611395673.USD","PNGAY","BK1506","LU1008478684.HKD","LU1366334578.USD","LU2153592121.USD","LU0862451753.SGD","LU0106252389.USD","LU1044874839.SGD","LU0307460666.USD","LU0049853897.USD","IE00BVYPNQ40.USD","LU0561508036.HKD","LU0823426308.USD","LU1051768304.USD","BK1607","SG9999002463.SGD","IE00BZ08YT58.USD","LU0359201885.HKD","LU0348816934.USD","000002","LU0821914370.USD","LU0488056044.USD","03750","LU0648948544.HKD","BK1191","LU1235295612.USD","LU1152091168.USD","LU0862451837.USD","LU0106959298.USD","LU0164880469.USD","LU1044875133.USD","LU0918141705.HKD","02318","LU1769817096.USD","601919","LU1282651121.HKD","LU0651946864.USD","IE0008368742.USD","LU1719994722.HKD","LU0918141887.USD","LU1820825898.SGD","LU0328353924.USD","LU1048596156.SGD","IE0034224299.USD","LU1048588211.SGD","LU1188198961.HKD","LU0163747925.USD","IE00B031HY20.USD","BK1555","IE00BZ18W340.USD","LU0043850808.USD","LU1880383366.USD","LU0797268264.HKD","HK0000320223.HKD","LU2348773727.SGD","IE00B29SXG58.USD","LU0784639295.USD","BK1185","BK1522","LU0762542818.HKD","LU1481107354.HKD","01919","06886","BK1103","LU0197773673.USD","LU2348774022.SGD","IE00BMCWC346.EUR","LU1961090484.USD","LU0588545490.SGD","LU0708995583.HKD","LU0456827905.SGD","LU0054450605.USD","LU0791590937.USD","LU2543165471.USD","LU0819123356.HKD","LU0531971595.HKD","LU0348784397.USD","LU0463099449.HKD","LU0211977185.USD","LU1831875114.USD","JEXYY","LU0072462343.USD","LU0650527681.SGD","LU1211504680.USD","LU1960683339.HKD","SG9999004220.SGD","IE00BYV24P56.USD","02768","BK1205","IE00BF5LJ272.USD","LU0165289439.USD","LU0441854154.USD","LU2152927971.USD","LU0348805143.USD","LU0348827113.USD","LU0540923850.HKD","LU0052750758.USD","LU1152091754.HKD","LU0084288322.USD","LU0327786744.USD","LU0417516902.SGD","LU1515016050.SGD","SG9999002562.SGD","000063","LU0348735423.USD","SG9999002950.SGD","BK1521","LU0244354667.USD","LU2778985437.USD","600875","601688","LU0880133367.SGD","IE00BZ18W456.USD","LU0417516571.SGD","LU2226246903.HKD","LU0348783662.USD","LU0254981946.USD","LU1813983027.USD","LU1642822792.SGD","LU0762540952.USD","LU0293314216.USD","LU0890818403.SGD","LU0588546209.SGD","01276","IE00BVYPNP33.GBP","LU0594300179.USD","300750","LU0791591158.USD","LU0196878994.USD","LU0828237940.HKD","LU0878005551.USD","LU0640798160.USD","LU1655091459.SGD","LU0117844026.USD","LU0630378429.USD","LU0149721374.USD","BK1564","IE0003895053.USD","LU0359201612.USD","LU0819121731.USD","LU0501845795.SGD","LU0634319403.HKD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613202402","title":"重新审视BigPharma创新质地：恒瑞、石药、中生、翰森、先声……","url":"https://stock-news.laohu8.com/highlight/detail?id=2613202402","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613202402?lang=zh_cn&edition=fundamental","pubTime":"2026-02-23 09:24","pubTimestamp":1771809843,"startTime":"0","endTime":"0","summary":"恒瑞医药、石药集团、中国生物制药、翰森药业、先声药业，作为国内药企创新梯队的核心成员，它们共享相似的历史起点——从仿制药的沃土中生长而来，却在这场历时数年的转型长跑中，走出了迥异的轨迹。代表性内资药企创新药获批情况作为行业龙头的恒瑞医药，其转型之路以稳著称，目前已全面进入创新产品的丰收期。2025年前三季度营收两位数下滑，当下，更需重新审视其创新药板块能否形成足够动能，带动业绩实现触底反弹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223093252a4bd7f73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223093252a4bd7f73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004220.SGD","02096","LU1226287792.SGD","LU1226287875.USD","LU0359202008.SGD","BK1515","LU1951186391.HKD","LU0501845795.SGD","LU1023057109.AUD","LU1960683339.HKD","LU0359201612.USD","LU1328277881.USD","01276","BK1191","01177","IE00B543WZ88.USD","LU0314109678.HKD","LU1226288170.HKD","LU1008478684.HKD","LU0140636845.USD","BK1583","LU1152091754.HKD","01093","LU1813983027.USD","LU0072913022.USD","IE0008368742.USD","LU0880133367.SGD","LU0359201885.HKD","LU1226288253.USD","BK1521","LU1152091168.USD","03692","LU2039709279.SGD","IE0008369823.USD","LU1807302812.USD","IE00B031HY20.USD","LU0315179316.USD","LU2543165471.USD","LU1226287529.USD","IE00B5MMRT66.SGD","BK1589","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","IE00BZ08YS42.EUR","LU0067412154.USD","HK0000165453.HKD","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612525502","title":"恒瑞医药(01276)出现大手成交10万股，成交价$69.7，涉资697万","url":"https://stock-news.laohu8.com/highlight/detail?id=2612525502","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612525502?lang=zh_cn&edition=fundamental","pubTime":"2026-02-20 14:52","pubTimestamp":1771570320,"startTime":"0","endTime":"0","summary":"[大手成交]恒瑞医药(01276)在下午02:52出现大手成交，成交量为10万，成交价为港币$69.7，涉资697万。至目前为止，股价跌1.763%，今日最高价为$70.9，而最低价为$68.45，总成交量为136.614万股，总成交金额港币$9.491千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908927_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2602206504/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2602206504/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0188","BK0012","LU1997244956.HKD","LU0405327494.USD","LU1023057109.AUD","LU1255011170.USD","LU2148510915.USD","BK0028","LU2097828557.USD","LU1781817850.SGD","LU1064130708.USD","BK0060","LU0359201612.USD","LU1997245177.USD","BK0239","LU1969619763.USD","LU1064131003.USD","LU2328871848.SGD","LU1655091616.SGD","LU1580142542.USD","LU2289578879.USD","LU2488822045.USD","01276","600276","LU1997245094.SGD","LU0359202008.SGD","BK0183","BK1191","LU1146622755.USD","LU2495084118.USD","LU2580892862.HKD","LU2097828714.EUR","BK0196","LU2097828474.EUR","LU2097828805.USD","LU2580892789.USD","LU1820825898.SGD","LU2543165471.USD","LU0405327148.USD","LU0359201885.HKD","LU1328615791.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612401348","title":"2.2类改良，恒瑞医药2款1类新药迎来新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2612401348","media":"北京药研汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612401348?lang=zh_cn&edition=fundamental","pubTime":"2026-02-19 08:01","pubTimestamp":1771459296,"startTime":"0","endTime":"0","summary":"2026年2月15日，据中国国家药品审评中心官网最新公示，恒瑞医药子公司苏州盛迪亚生物医药有限公司及上海盛迪医药有限公司按注册分类2.2类申报的SHR-8068注射液、阿得贝利单抗注射液临床试验申请获默示许可。SHR-8068注射液是恒瑞医药自基石药业引进的一款全人源抗CTLA-4单克隆抗体，它可增强抗肿瘤免疫效应。希望恒瑞医药的SHR-8068注射液、阿得贝利单抗注射液后续相关临床试验顺利推进，早日为广大患者提供更多的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219081347a4b1afae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219081347a4b1afae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023057109.AUD","BK1191","LU2543165471.USD","LU0359202008.SGD","LU0359201885.HKD","01276","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611417077","title":"《大行》野村料恒瑞医药今年净利润增长三成 降目标价至87.49元续吁“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2611417077","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611417077?lang=zh_cn&edition=fundamental","pubTime":"2026-02-16 11:24","pubTimestamp":1771212240,"startTime":"0","endTime":"0","summary":"期内毛利率预期按年扩张0.6个百分点至86.5%，经营利润率则扩张1.8个百分点至24.2%。因此，该行估算期内归属股东净利润按年增长32%至23亿元。加上预期毛利率及经营利润率分别按年扩张至87.3%及30.1%，料净利润将按年增长30%至112亿元，高于市场预期升13%。该行将恒瑞医药2025及2026年收入增长预测分别下调8.7%及3.1%，盈利增长预测分别下调18.7%及2.6%，主要反映2025年合作收入确认时间有所延迟。目标价由94.54港元降至87.49港元，维持“买入”评级。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250603120312570_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250603120312570_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1503557/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1503557/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["600276","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611396112","title":"这款肿瘤药断供数月，患者陷入困境 实探“封门”风波中的璎黎药业，现场工作人员：整体搬迁，经营没有大问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2611396112","media":"每经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611396112?lang=zh_cn&edition=fundamental","pubTime":"2026-02-14 17:02","pubTimestamp":1771059770,"startTime":"0","endTime":"0","summary":"一名璎黎药业工作人员向记者表示，公司确实正在整体搬迁，主要原因是“和房东有一些租房上的纠纷，并不是企业经营有什么大的问题”。实探璎黎药业：正在搬迁，员工称公司现有30多人一纸封条，让璎黎药业的经营状况备受关注。璎黎药业还表示，将积极应对经营过程中的各类挑战，全力保障员工、合作伙伴及患者的合法权益。实际上，在璎黎药业陷入“封门”风波前，其核心产品林普利塞就已出现断供缺货的情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021417033895412434&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021417033895412434&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","LU0359201612.USD","LU1023057109.AUD","LU0359202008.SGD","01276","BK1191","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611112319","title":"江苏：医保搭台推进创新药落地再提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2611112319","media":"金台资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611112319?lang=zh_cn&edition=fundamental","pubTime":"2026-02-14 07:24","pubTimestamp":1771025052,"startTime":"0","endTime":"0","summary":"江苏医保巧搭台，创新药落地再提速——让患者用上更多新药好药2月5日，一场别开生面的多方沟通会在宁举行。2025年，江苏产的41种药品成功准入国家医保目录，占全国新增数量的比重超过三分之一，再创历史新高。它们共同构成江苏生物医药产业创新“雁阵”，数据显示，江苏生物医药产业产值规模已近5000亿元，稳居全国首位。江苏医保部门除了搭建沟通平台，一系列创新医保政策的出台，也在不断降低新药上市门槛。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214072749a4a2543f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260214072749a4a2543f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","06978","LU0359201885.HKD","LU0359201612.USD","LU2543165471.USD","01801","BK1191","BK1161","01276","LU1023057109.AUD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}